Colorectal Cancer Drug Pipeline Update 2007
Until a decade ago, 5FU/leucovorin formed the mainstay of colorectal cancer treatment but Camptosar and Eloxatin quickly established themselves as components of gold-standard therapy. The advent of Avastin and Erbitux heralded a new era in the disease management, and the emergence of other molecular targeted agents should further push survival to an unprecedented level in the coming years.There are today more than 240 therapeutics targeting colorectal cancer, from early preclinical to marketed drugs. Colorectal Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 130 different targets. These targets are further categorized on the CD-ROM by 46 classifications of molecular function and their possible belonging to 19 different signaling pathways in the cell.
Benefits of this product
| http://www.bioseeker.com/component/page,shop.product_details/flypage,shop.flypage/product_id,3/option,com_virtuemart/Itemid,1/ |
- Show investors/board/management that you are right on top of drug development progress in your therapeutic area.
- Find competitors, collaborations partners, M&A candidates etc.
- Jump start competitive drug intelligence operations
- Excellent starting point for world wide benchmarking
- Compare portfolio and therapy focus with your peers
- Speed up pro-active in-/out licensing strategy work
- Fast and easy way of tracking drugs using search engines; just one click and you may search the World Wide Web and PubMed for any drug.
Drug Pipeline Update is delivered to you as a CD-ROM application, which requires no installation on your computer
Other users found this report page using the following search terms: colorectal cancer
If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.